1 |
Layon AJ, Modell JH. Drowning: Update 2009[J]. Anesthesiology, 2009, 110(6):1390-1401.
|
2 |
周长喜,钱桂生,杨昱,等. 海水淹溺型肺损伤与淡水淹溺型肺损伤特征的比较[J]. 解放军医学杂志,2009, 34(4):393-396.
|
3 |
Swieringa F, Spronk HMH, Heemskerk JWM, et al. Integrating platelet and coagulation activation in fibrin clot formation[J]. Res Pract Thromb Haemost, 2018, 2(3):450-460.
|
4 |
Rossaint J, Margraf A, Zarbock A. Role of Platelets in Leukocyte Recruitment and Resolution of Inflammation[J]. Front Immunol, 2018, 9:2712.
|
5 |
Kubes P. The versatile platelet contributes to inflammation, infection,hemostasis, coagulation and cancer[J]. Semin Immunol, 2016, 28(6):535.
|
6 |
Zarbock A, Polanowska-Grabowska RK, Ley K. Platelet-neutrophil-interactions: linking hemostasis and inflammation[J]. Blood Rev, 2007, 21(2):99-111.
|
7 |
Page C, Pitchford S. Neutrophil and platelet complexes and their relevance to neutrophil recruitment and activation[J]. Int Immunopharmacol, 2013, 17(4):1176-1184.
|
8 |
Zarbock A, Singbartl K, Ley K. Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation[J]. J Clin Invest, 2006, 116(12):3211-3219.
|
9 |
邓云汐,芮蕾,陈威丞,等. 双联抗血小板对脓毒症大鼠血小板功能和急性肺损伤的影响[J]. 中国急救医学,2015, 35(2):97-100.
|
10 |
董慧宇,陈献华,钟文英,等. P2Y_12_受体拮抗剂类抗血小板药物的研究新进展[J]. 中国新药杂志,2017, 26(12):1406-1411.
|
11 |
Thomas MR, Storey RF. Effect of P2Y12 inhibitors on inflammation and immunity[J]. Thromb Haemost, 2015, 114(3):490-497.
|
12 |
Totani L, Dell′Elba G, Martelli N, et al. Prasugrel inhibits platelet-leukocyte interaction and reduces inflammatory markers in a model of endotoxic shock in the mouse[J]. Thromb Haemost, 2012, 107(6):1130-1140.
|
13 |
刘庆睛,金发光,薄丽艳,等. Ang Ⅱ及其受体AT1在海水吸人型肺损伤中的作用及机制的研究[J]. 国际呼吸杂志,2014, 34(10):736-740.
|
14 |
王瑞璇,马李杰,金发光. 海水吸入型急性呼吸窘迫综合征发病机制的研究进展[J]. 国际呼吸杂志,2016, 36(1):60-64.
|
15 |
Cedervall J, Hamidi A, Olsson AK. Platelets, NETs and cancer[J]. Thromb Res, 2018, 164(Suppl 1):S148-S152.
|
16 |
Manne BK, Xiang SC, Rondina MT. Platelet secretion in inflammatory and infectious diseases[J]. Platelets, 2017, 28(2):155-164.
|
17 |
Mcfadyen JD, Kaplan ZS. Platelets are not just for clots[J]. Transfus Med Rev, 2015, 29(2):110-119.
|
18 |
Maugeri N, Capobianco A, Rovere-Querini P, et al. Platelet microparticles sustain autophagy-associated activation of neutrophils in systemic sclerosis[J]. Sci Transl Med, 2018, 10(451): doi: 10.1126/scitranslmed.aao3089.
|
19 |
Jenne CN, Kubes P. Platelets in inflammation and infection[J]. Platelets, 2015, 26(4):286-292.
|
20 |
Assinger A, Laky M, Schabbauer G, et al. Efficient phagocytosis of periodontopathogens by neutrophils requires plasma factors, platelets and TLR2[J]. J Thromb Haemost, 2011, 9(4):799-809.
|
21 |
Elzey BD, Ratliff TL, Sowa JM, et al. Platelet CD40L at the interface of adaptive immunity[J]. Thromb Res, 2011, 127(3):180-183.
|
22 |
Coenen DM, Mastenbroek TG, Cosemans J. Platelet interaction with activated endothelium: mechanistic insights from microfluidics[J]. Blood, 2017, 130(26):2819-2828.
|
23 |
Dziedzic A, Bijak M. Interactions between platelets and leukocytes in pathogenesis of multiple sclerosis[J]. Adv Clin Exp Med, 2018, doi: 10.17219/acem/83588.
|
24 |
Kaur R, Kaur M, Singh J. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies[J]. Cardiovasc Diabetol, 2018, 17(1):121.
|
25 |
Gao Y, Yu C, Pi S, et al. The role of P2Y12 receptor in ischemic stroke of atherosclerotic origin[J]. Cell Mol Life Sci, 2019, 76(2):341-354.
|
26 |
Adamski P, Adamska U, Ostrowska M, et al. Evaluating current and emerging antithrombotic therapy currently available for the treatment of acute coronary syndrome in geriatric populations[J]. Expert Opin Pharmacother, 2018, 19(13):1415-1425.
|
27 |
Gresele P, Momi S, Malvestiti M, et al. Platelet-targeted pharmacologic treatments as anti-cancer therapy[J]. Cancer Metastasis Rev, 2017, 36(2):331-355.
|
28 |
Thomas MR, Outteridge SN, Ajjan RA, et al. Platelet P2Y12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model[J]. Arterioscler Thromb Vasc Biol, 2015, 35(12):2562-2570.
|
29 |
Paliogiannis P, Satta R, Deligia G, et al. Associations between the neutrophil-to-lymphocyte and the platelet-to-lymphocyte ratios and the presence and severity of psoriasis: a systematic review and meta-analysis[J]. Clin Exp Med, 2018, doi: 10.1007/s10238-018-0538-x.
|
30 |
Guo J, Fang J, Huang X, et al. Prognostic role of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in prostate cancer: A meta-analysis of results from multivariate analysis[J]. Int J Surg, 2018, 60:216-223.
|